Md. Federal Judge Dismisses Qui Tam Suit Alleging Off-Label Marketing of Pain Patch



DOCUMENTS
  • Order


BALTIMORE — A Maryland federal judge has dismissed without prejudice a lawsuit brought under the False Claims Act in which a relator accused drug makers of aggressively marketing a transdermal pain patch for off-label uses, ruling that it is barred by the FCA’s “first-filed rule.”

On Dec. 16, Judge Ellen Lipton Hollander of the U.S. District Court for the District of Maryland explained that a similar qui tam action was pending when the instant case was filed and thus dismissal without prejudice is mandatory, pursuant to 4th Circuit case law.

Jerome Palmieri filed a qui tam action on April 20, …

FIRM NAMES
  • Kirkland & Ellis
  • Shelsby & Leoni
  • The Shephard Law Firm
  • Thomas F. Corcoran
  • Tydings & Rosenberg





UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS